Response to "Use of nasal potential differences and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis".
Vicky A
VA
LeGrys
D018118:Chloride Channels / Q000032:analysis*; D002986:Clinical Trials as Topic / Q000592:standards*; D003550:Cystic Fibrosis / Q000378:metabolism* / Q000503:physiopathology*; D006801:Humans; D008564:Membrane Potentials; D015337:Multicenter Studies as Topic / Q000592:standards*; D009297:Nasal Mucosa / Q000503:physiopathology*; D017063:Outcome Assessment, Health Care / Q000592:standards*; D013542:Sweat / Q000737:chemistry*
D018118:Chloride Channels